Adhesión real al dimetilfumarato en pacientes con esclerosis múltiple remitente-recurrente

INTRODUCTION. Multiple sclerosis is a chronic neurological disease with numerous disease-modifying treatments available, including dimethyl fumarate (DMF), a first-line therapy for relapsing-remitting multiple sclerosis. Although rates of discontinuation of DMF are generally low in clinical trials,...

Descripción completa

Detalles Bibliográficos
Autores principales: de Sá, João, Ferreira, João, Macedo, Ana M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Viguera Editores (Evidenze Group) 2023
Materias:
Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478096/
https://www.ncbi.nlm.nih.gov/pubmed/36683265
http://dx.doi.org/10.33588/rn.76S01.2022296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478096/
https://www.ncbi.nlm.nih.gov/pubmed/36683265
http://dx.doi.org/10.33588/rn.76S01.2022296

Ejemplares similares